This MR study indicated a causal association between genetically determined psoriasis and an elevated risk of lipid metabolism levels and MI, with evidence that the LDL cholesterol, apolipoprotein B, and lipoprotein A mediated the effect of psoriasis on the MI risk. The gene discussed is APOB; the disease is psoriasis.